Pharmafile Logo
Pharmafocus logo
Advanced Search

Big drop in animal rights attacks

January 31, 2006
Sales and Marketing

The number of attacks by animal rights extremists saw a significant fall in 2005, with new laws introduced during the …

News

Europe approves first ever biotech generic

January 30, 2006
Sales and Marketing

Europe's medicines regulator has approved Sandoz's Omnitrope, the world's first generic equivalent or 'biosimilar' of an existing biotech drug.Patents on …

News

Merck battling more lawsuits over Vioxx

January 27, 2006
Sales and Marketing

Merck says that it will conduct a vigorous defence in the lawsuit brought by the family of Leonel Garza, who …

News

‘Break even culture’ must end, Hewitt tells NHS

January 27, 2006

Health secretary Patricia Hewitt has unveiled the strategic and financial framework for the NHS in 2006/7, re-stating the government's pledge …

News

Humira becomes Britain’s first biotech blockbuster

January 26, 2006
Research and Development

The UK biotech company which discovered rheumatoid arthritis drug Humira has hailed its success after sales passed the $1 billion …

News

Eisai invests

January 26, 2006
Manufacturing and Production

Japanese pharma company Eisai is to open a major new single site facility in the UK, marking the country out …

News

Amgen to expand R&D investment in UK

January 26, 2006
Research and Development

Amgen, the world's largest biotechnology company is to open a new drug development centre in Uxbridge, London, as part of …

News

Helping marketers to break ranks

January 26, 2006
Business Services

In the pharma industry personnel development seems to be viewed from a short-term perspective. Where personnel development is undertaken, process …

Feature

Limited access to Alzheimer’s drugs leaves patients groups dissatisfied

January 25, 2006
Sales and Marketing

Patient groups have expressed disappointment at NICE plans to allow only some patients with Alzheimer's disease to have drug treatment, …

News

Roche and biotech swap roles in novel collaboration

January 24, 2006
Research and Development

Roche and Amira Pharmaceuticals have entered into a new and unorthodox drug discovery and development partnership which will see them …

News

Mergers will create gulf between GPs and PCTs

January 20, 2006

Health service leaders have warned that planned mergers of Primary Care Trusts in England will create larger bodies more remote …

News

Wyeth submits follow-up to antidepressant blockbuster

January 20, 2006
Sales and Marketing

Wyeth has submitted its new antidepressant desvenlafaxine to the FDA, a drug it hopes will be a successor to its …

News

Next generation hypertension drug ready for 2006 filing

January 20, 2006
Sales and Marketing

Next generation hypertension drug aliskiren is on track for filing in late 2006 and is showing promising results in the …

News

Campaign to raise awareness of pharma code of conduct

January 20, 2006
Medical Communications

The UK pharmaceutical industry's newly re-drafted code of conduct is to benefit from a PR campaign to promote awareness of …

News

Next generation monoclonal antibodies to enter clinical trials in 2007

January 20, 2006
Research and Development Ablynx, Novartis

Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …

News

FDA looks to streamline early research

January 19, 2006
Research and Development

The FDA has unveiled plans to allow more small-scale exploratory studies of drugs in humans before formal phase I studies …

News

Novartis to appeal Zelnorm rejection

January 18, 2006
Sales and Marketing

Novartis says it will appeal against an EMEA decision not to recommend its irritable bowel syndrome drug Zelnorm. Zelnorm (tegaserod) …

News

Prescribers ready to defy NICE in Alzheimer’s drug row

January 18, 2006
Sales and Marketing

Patient groups and manufacturers are hoping NICE will reverse its decision to deny access to Alzheimer's drugs on the NHS, …

News

First-in-class indication expected for Remicade

January 18, 2006
Sales and Marketing

Schering-Plough expects its arthritis treatment Remicade to receive European approval to treat ulcerative colitis in early 2006.If approved Remicade (infliximab) …

News

StayinFront wins Roche regional contract

January 18, 2006
Business Services

Roche will equip its Central and Eastern European salesforces with StayinFront customer relationship management software after expanding its current contract …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025